BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15744246)

  • 1. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
    Vakili A; Kataoka H; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice.
    Trabold R; Krieg S; Schöller K; Plesnila N
    J Neurotrauma; 2008 Dec; 25(12):1459-65. PubMed ID: 19118456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
    Gröger M; Lebesgue D; Pruneau D; Relton J; Kim SW; Nussberger J; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):978-89. PubMed ID: 15815587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.
    Liu X; Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
    Neurocrit Care; 2010 Feb; 12(1):124-31. PubMed ID: 19806476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat.
    Masada T; Hua Y; Xi G; Ennis SR; Keep RF
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):22-33. PubMed ID: 11149665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
    Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
    Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet.
    Lo AC; Chen AY; Hung VK; Yaw LP; Fung MK; Ho MC; Tsang MC; Chung SS; Chung SK
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):998-1011. PubMed ID: 15815585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
    Vakili A; Hosseinzadeh F; Sadogh T
    Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
    Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin-induced brain edema is mediated by the V1 receptor.
    Rosenberg GA; Estrada E; Kyner WT
    Adv Neurol; 1990; 52():149-54. PubMed ID: 2144395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of arginine vasopressin receptor antagonist on the rat cold-injured brain].
    Kagawa M; Nagao S
    No Shinkei Geka; 1993 Dec; 21(12):1103-7. PubMed ID: 8259220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of arginine vasopressin on the cortex edema in the ischemic stroke of Mongolian gerbils.
    Zhao XY; Wu CF; Yang J; Gao Y; Sun FJ; Wang DX; Wang CH; Lin BC
    Neuropeptides; 2015 Jun; 51():55-62. PubMed ID: 25843346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of arginine vasopressin receptors and angiotensin receptor subtypes on the water intake and arterial blood pressure induced by vasopressin injected into the lateral septal area of the rat.
    Abrão Saad W; Antonio De Arruda Camargo L; Sérgio Cerri P; Simões S; Abrão Saad W; Garcia G; Izabel Gutierrez L; Guarda I; Saad Guarda R
    Auton Neurosci; 2004 Mar; 111(1):66-70. PubMed ID: 15109940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporary and permanent focal cerebral ischemia in the mouse: assessment of cerebral blood flow, brain damage and blood-brain barrier permeability.
    Mao Y; Yang G; Zhou L
    Chin Med J (Engl); 2000 Apr; 113(4):361-6. PubMed ID: 11775237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Through V2, not V1 receptor relating to endogenous opiate peptides, arginine vasopressin in periaqueductal gray regulates antinociception in the rat.
    Yang J; Chen JM; Liu WY; Song CY; Lin BC
    Regul Pept; 2006 Dec; 137(3):156-61. PubMed ID: 17011056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oxygen therapy on brain damage and cerebral pO(2) in transient focal cerebral ischemia in the rat.
    Hou H; Grinberg O; Williams B; Grinberg S; Yu H; Alvarenga DL; Wallach H; Buckey J; Swartz HM
    Physiol Meas; 2007 Aug; 28(8):963-76. PubMed ID: 17664686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice.
    Chen HY; Chen TY; Lee MY; Chen ST; Hsu YS; Kuo YL; Chang GL; Wu TS; Lee EJ
    J Pineal Res; 2006 Sep; 41(2):175-82. PubMed ID: 16879324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia.
    Schöller K; Zausinger S; Baethmann A; Schmid-Elsaesser R
    Brain Res; 2004 Oct; 1023(2):272-8. PubMed ID: 15374753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia.
    Hayashi T; Abe K; Itoyama Y
    J Cereb Blood Flow Metab; 1998 Aug; 18(8):887-95. PubMed ID: 9701350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia.
    Sato T; Morishima Y; Shirasaki Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1042-7. PubMed ID: 12604680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.